Richard Charles Garratt

Title: Richard Charles Garratt: Innovator in Peptide Technology

Introduction

Richard Charles Garratt is a notable inventor based in Sao Paulo, Brazil. He has made significant contributions to the field of peptide technology, holding three patents that showcase his innovative work. His research focuses on synthetic active peptide fragments, which have important applications in immunology and diagnostics.

Latest Patents

Garratt's latest patents revolve around synthetic active peptide fragments. These peptide fragments share amino acid sequences with specific portions of the 14 kDa protein of SM14 or related Fatty Acid Binding Proteins (FABPs). The invention details how these peptide fragments can function as continuous or discontinuous epitopic regions of the molecule, mimicking its biological activity. Furthermore, the patents describe methods for constructing these active peptide fragments, as well as the development of immunogenic compositions and diagnostic kits utilizing these fragments.

Career Highlights

Throughout his career, Garratt has worked with prominent institutions, including the Fundação Oswaldo Cruz (Fiocruz). His work at Fiocruz has allowed him to contribute to significant advancements in health and biotechnology. His expertise in peptide technology has positioned him as a key figure in his field.

Collaborations

Garratt has collaborated with esteemed colleagues such as Miriam Tendler and Naftale Katz. These partnerships have further enriched his research and development efforts in peptide technology.

Conclusion

Richard Charles Garratt is a distinguished inventor whose work in synthetic active peptide fragments has the potential to impact various fields, including immunology and diagnostics. His contributions continue to advance the understanding and application of peptide technology.